MDS Foundation

The MDS Foundation is a global non-profit advocacy organization that for over 25 years has supported patients and their families as well as healthcare providers in the fields of MDS and its related diseases. Every MDS patient will benefit from our initiatives and research as early as possible.
MDS Foundation ...
read more ↘

Debates in HR-MDS: Cytoreduction Should Precede Allo-HCT

By MDS Foundation FEATURING Uwe Platzbecker

170 views

February 13, 2024

0 Comments

Login

Login

Join VuMedi

MDS Foundation

Debates in HR-MDS: Cytoreduction Should Precede Allo-HCT

A proven CD123 targeted therapy for BPDCN

New Approval for Frontline Consolidation in Patients with CD19-posit…

Debates in HR-MDS: Cytoreduction Should Precede Allo-HCT

Debates in HR-MDS: Cytoreduction Should NOT Precede allo-HCT

Experts Discuss CCUS Cases: 68 y/o Male With Anemia & 66 y/o Male Wi…

Expert Case Discussion: 86 y/o Male With Co-Occurring Lymphoma and M…

Debates in LR-MDS: ESAs are NOT the Optimal Choice for 1L

Debates in LR-MDS: ESAs are the Optimal Choice for 1L

How Artificial Intelligence Will Impact Clinical Practice For MDS

Current Challenges in the Diagnosis, Prognosis and Treatment of MDS

A Classification of MDS That Aids Clinical Decision-Making

Pre-MDS States: How to Manage CHIP, CCUS and ICUS in the Clinic

Can We Do Better Than HMA in HR-MDS?